1. Search Result
Search Result
Results for "

CB-300919

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-14375
    CB 300919

    NAMPT Cancer
    CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.